alpha CD40 (Medimmune)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namealpha CD40 (Medimmune)
Drug Alias NameCD40 costimulator (Medimmune)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Oncology Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A